Morgan Stanley lowered the firm’s price target on Walgreens Boots Alliance to $20 from $21 and keeps an Underweight rating on the shares. The firm says it is somewhat surprised the stock held up on the latest mixed print and reduced EPS guide on a lingering lackluster retail environment, but admittedly expectations weren’t overly high heading into the print. Morgan Stanley argues the same debate remains around visibility on the turnaround.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Walgreens Boots Alliance CEO: We’re focused on improving front end of the store
- Walgreens Announces Executive Leadership Transition and Consultancy
- Unusually active option classes on open March 28th
- WBA Earnings: Walgreens Tanks on Narrowed Outlook
- Options Volatility and Implied Earnings Moves Today, March 28, 2024
